Curr Drug Metab 2006
Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist Tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial
Kirtley says the inflammation in her once arthritic knee is mostly gone
DOI: Published online: January 15, 2025 1 Department of Endocrinology, Mymensingh Medical College, Mymensingh, Bangladesh 2 Department of Medicine, Army Medical College Cumilla, Cumilla, Bangladesh 3 Department of Endocrinology, CEDAR Superspeciality Clinics, New Delhi, India 4 Department of Endocrinology, National Hospital of Sri Lanka, Colombo, Sri Lanka 5 Department of Obstetrics and Gynecology, Atpara Upazila Health Complex, Netrokona, Bangladesh 6 Department of Endocrinology, JSS Medical College, JSS Academy of Higher Education and Research, Mysore, India Corresponding author: A.B.M